Roche Holding AG

Swiss Stock Exchange RO.SW

Roche Holding AG Net Income Margin for the year ending December 31, 2023: 19.02%

Roche Holding AG Net Income Margin is 19.02% for the year ending December 31, 2023, a -3.08% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Roche Holding AG Net Income Margin for the year ending December 31, 2022 was 19.63%, a -11.51% change year over year.
Roche Holding AG Net Income Margin for the year ending December 31, 2021 was 22.18%, a -9.50% change year over year.
Roche Holding AG Net Income Margin for the year ending December 31, 2020 was 24.51%, a 15.77% change year over year.
Roche Holding AG Net Income Margin for the year ending December 31, 2019 was 21.17%, a 19.97% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

Swiss Stock Exchange: RO.SW

Roche Holding AG

CEO	Dr. Thomas Schinecker
IPO Date	Aug. 3, 1995
Location	Switzerland
Headquarters	Konzern Hauptsitz
Employees	103,605
Sector	Health Care
Industries Pharmaceuticals

Description

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Key trends

Past 5 years